HIV rapid testing in drug treatment: comparison across treatment modalities
- PMID: 23021496
- PMCID: PMC3577980
- DOI: 10.1016/j.jsat.2012.08.219
HIV rapid testing in drug treatment: comparison across treatment modalities
Abstract
Despite high rates of risky behavior among patients, many drug abuse treatment programs do not provide on-site HIV testing. This secondary analysis examined differences in outcome by program modality from a multi-site trial in which 1281 HIV-negative patients in three methadone programs, seven non-methadone outpatient programs, and three residential programs were randomly assigned to: (1) off-site referral for HIV risk reduction counseling and testing; or on-site rapid testing (2) with or (3) without risk reduction counseling. The parent study using generalized estimating equations with site as a cluster variable found significantly higher rates of HIV testing and feedback of results by 1 month post-enrollment for the combined on-site conditions compared to the offsite condition [RR=4.52, 97.5% CI (3.57, 5.72)]. Utilizing the same statistical approach, we found neither significant treatment modality nor significant treatment modality by testing condition interaction effects either for receipt of HIV test results at 1 month or for sexual or drug use HIV-risk behaviors at 6-month follow-up. On-site HIV testing is effective across treatment modalities for achieving high rates of testing and results feedback. All programs should be encouraged to adopt or expand this service.
Copyright © 2013 Elsevier Inc. All rights reserved.
Conflict of interest statement
All authors have seen and approved the manuscript, have contributed significantly to the work, and have no financial conflicts of interest.
Figures
References
-
- Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE Centers for Disease Control Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. [Practice Guideline] MMWR Recommendations and Reports. 2006;55:1–17. quiz CE11-14. - PubMed
-
- Brown LS, Kritz SA, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, Robinson J, McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment. 2006;30:315–321. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- U10 DA 13727/DA/NIDA NIH HHS/United States
- U10 DA020036/DA/NIDA NIH HHS/United States
- K23 AA020316/AA/NIAAA NIH HHS/United States
- K23DA019809/DA/NIDA NIH HHS/United States
- R01DA027379/DA/NIDA NIH HHS/United States
- U10DA13720-09S/DA/NIDA NIH HHS/United States
- U10 DA013732/DA/NIDA NIH HHS/United States
- U10 DA13036/DA/NIDA NIH HHS/United States
- K23 DA019809/DA/NIDA NIH HHS/United States
- U10 DA013034/DA/NIDA NIH HHS/United States
- U10 DA015815/DA/NIDA NIH HHS/United States
- U10 DA013720/DA/NIDA NIH HHS/United States
- U10DA15815/DA/NIDA NIH HHS/United States
- U10DA13034/DA/NIDA NIH HHS/United States
- R01 DA027379/DA/NIDA NIH HHS/United States
- HHSN271200522071C/DA/NIDA NIH HHS/United States
- U10 DA013036/DA/NIDA NIH HHS/United States
- U10 DA013727/DA/NIDA NIH HHS/United States
- U10 DA015833/DA/NIDA NIH HHS/United States
- U10 DA013038/DA/NIDA NIH HHS/United States
- U10DA013038/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical